@article{article, title  = {{LBA28 STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC)}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2021}},

 month = {{9}},

 author = {{Brown JE and Royle K-L and Ralph C and Meads D and Martin A and Howard H and Linsley C and Swain J and Powles TB and Jones R and Eisen T et al}},

 doi = {{10.1016/j.annonc.2021.08.2104}},

 volume = {{32}},

 journal = {{Annals of Oncology}},

 pages = {{S1303-S1304}},

 note = {{Accessed on 2024/12/27}}}